1. The Role of Next Generation Sequencing in Diagnosis of Brain Tumors: A Review Study
- Author
-
Jafar Ai, Sadegh Shirian, Amir Ghaemi, Arman Ai, Arash Goodarzi, Akbar Ahmadi, Ahmad Emadi, Maryam Ghavideldarestani, Yahya Daneshbod, and Saranaz Jangjoo
- Subjects
030506 rehabilitation ,Review study ,business.industry ,General Neuroscience ,Treatment options ,Computational biology ,Human brain ,DNA sequencing ,Molecular analysis ,Clinical Practice ,03 medical and health sciences ,Psychiatry and Mental health ,0302 clinical medicine ,medicine.anatomical_structure ,Pathognomonic ,Medicine ,Neurology (clinical) ,Target therapy ,0305 other medical science ,business ,030217 neurology & neurosurgery - Abstract
Since the number of prognostic and predictive neuro-oncologic genetic markers is steadily increasing, a comprehensive analysis of the molecular techniques used to examine neuro-oncology samples is vastly required. Molecular analysis and profiling of brain malignancies result in improved diagnostic accuracy, target identification, and predictive prognosis. Application of high-throughput molecular approaches, such as next generation sequencing (NGS), to analyze brain tumors has provided a large amount of molecular information. In the clinical practice, the application of NGS has been increased, which has consequently improved the treatment option for brain cancer as well as other types of malignancies. Target therapy has recently become one of the most promising treatment options for various tumors, especially brain tumors. In this review, we provided and summarized high-throughput genomic studies, such as NGS technique, that could independently identify the integrated management and diagnosis of primary human brain tumors across a variety of entities with pathognomonic genetic alterations.
- Published
- 2019
- Full Text
- View/download PDF